Investigative: What 30 Billion CFU Really Means on a Dog Probiotic Soft Chew Label
Our Investigations Desk —
On this page
Key Takeaways
- A label-stated CFU count represents organisms present at the moment of manufacture, not necessarily at the point of sale or end of shelf life.
- No major soft chew brand currently publishes third-party verified CFU data measured at retail purchase date across the full shelf life.
- Moisture, heat, and oxygen exposure inherent to soft chew formats create documented viability challenges for live bacterial organisms.
- Probiotic formulations that avoid live organisms entirely sidestep the stability question but raise separate questions about mechanism of action.
- Manufacturer responses to direct inquiries about point-of-sale viability data were uniform: no such data was available for public review.
Walk the supplement aisle of any pet retailer or scroll through the top results on a canine probiotic search and you will see a number repeated with almost ritualistic confidence: 30 billion CFU. Sometimes 25 billion. Sometimes 50. The figure is large, rounded, and presented as a badge of potency. But what does that number actually represent, and at what point in a soft chew’s journey from the manufacturing line to a dog’s food bowl does it still hold true?
This investigation examined the publicly available evidence behind high-CFU claims on soft chew probiotic products marketed to dog owners. We reviewed manufacturer disclosures, peer-reviewed stability literature, FDA labeling guidance, and the responses we received when we asked brands directly about point-of-sale viability testing. The findings raise questions that consumers are not typically given the tools to answer.
Disclosure: This article may contain affiliate links. If you purchase through these links, we may earn a small commission at no extra cost to you. This does not affect our editorial independence.
The Label Number and What It Legally Represents
A colony-forming unit (CFU) count on a supplement label is, under current FDA guidance for dietary supplements, a representation of viable organisms at the time of manufacture. The agency’s Dietary Supplement Labeling Guide does not require manufacturers to disclose the CFU count at expiration, though some companies do so voluntarily.
This distinction matters enormously for soft chew products. A soft chew is a moisture-containing matrix, typically 15-25% water activity, often packaged in jars or pouches that are opened and closed repeatedly by consumers. Each opening introduces oxygen and potential humidity exchange. The bacterial organisms embedded in that matrix face conditions that powdered or capsule formats do not.
When a label states “30 billion CFU per serving,” a reasonable consumer reading would be that each chew delivered today contains 30 billion live organisms. Whether that reading aligns with physical reality is a different question.
What Peer-Reviewed Stability Research Shows
The scientific literature on probiotic viability in non-refrigerated formats is not reassuring. A 2021 review in the Journal of Functional Foods examined probiotic survival across various delivery matrices and documented significant viability losses for Lactobacillus and Bifidobacterium species in moisture-containing formats stored at ambient temperatures, with some studies reporting losses exceeding 90% over six months.
More recently, researchers have called attention to the gap between label claims and tested viability. The body of evidence suggests that without water activity control, microencapsulation, or sachet-level barrier packaging, soft chews are among the least stable formats available for live probiotic delivery.
Manufacturer Outreach: What We Asked and What We Received
We contacted five manufacturers marketing soft chew probiotics with label claims of 25 billion CFU or higher, asking three specific questions:
- Do you conduct third-party verified CFU testing at the point of sale (i.e., at retail purchase date or end of shelf life)?
- If yes, are those results published or made available to consumers?
- What packaging technology or formulation approach is used to maintain viability across the product’s shelf life?
Four of the five companies responded. Three declined to answer the questions directly, referring us instead to their general quality assurance statements and NASC (National Animal Supplement Council) certifications. One company provided a written response explaining that point-of-sale viability testing is conducted internally but is not published, citing proprietary formulation considerations.
The NASC Quality Seal, which appeared on all five product labels, is worth noting here. The seal certifies that a manufacturer follows certain GMP (Good Manufacturing Practice) protocols and has passed an independent audit. It does not certify label accuracy of CFU counts at any specific time point. The distinction is significant and rarely surfaced in marketing materials.
The Stability Data Gap
Our investigation uncovered a notable pattern: while manufacturers readily point to their GMP certifications and ingredient sourcing standards, publicly accessible stability data confirming label-stated CFU at the point of sale was absent across the category. This is not necessarily evidence of misconduct. Stability testing is expensive, and smaller brands may not have the resources. But the absence of such data means consumers are making purchasing decisions based on a number that cannot be independently verified outside of a laboratory the brand does not operate in public view.
For a thorough discussion of how other common supplement marketing claims are constructed and verified, see our investigation into “Clinically Proven” claims in pet supplement advertising.
The Format Problem: Soft Chew-Specific Challenges
Soft chew formats present particular stability challenges rooted in their physical structure. Unlike capsules (which provide a sealed, low-moisture environment) or freeze-dried powders (which can be sealed in single-serve sachets), soft chews are by definition moist. That moisture supports bacterial survival in the short term but creates ongoing metabolic activity that depletes viable organisms over time.
The economic tradeoffs in this space are worth understanding. We examined ingredient budgets across delivery formats in our earlier analysis on soft chew economics and ingredient quality budgets. The pattern is consistent: the format itself imposes costs that often crowd out investment in stability testing or barrier packaging technology.
What a Reader Can Verify Independently
Short of sending a product to an independent microbiology lab, a consumer has limited tools. Some third-party testing services (such as ConsumerLab, where applicable to pet products) periodically test for label accuracy, but coverage of canine soft chews is inconsistent. Asking a manufacturer for a certificate of analysis (CoA) for a specific production lot is a reasonable step; whether that request will be fulfilled is another matter.
Alternative Approaches and Their Tradeoffs
Not all products marketed for canine digestive health rely on live organisms. Some formulations use postbiotics (inactivated bacterial cells or their metabolites), prebiotics (non-digestible fibers that feed existing gut bacteria), or combinations thereof. These formats sidestep the live-organism stability question entirely because there are no live organisms to degrade.
The tradeoff is mechanistic: postbiotics and prebiotics work through different pathways than live probiotics, and the evidence base for each is distinct. A recent canine clinical trial examined a postbiotic and prebiotic oral health formulation and reported measurable effects on plaque and gingival indices (PMID: 40509062). Another trial examined gut-skin axis outcomes with a similar multi-system approach (PMID: 40723482). These studies represent the kind of product-specific canine evidence that live-probiotic soft chew manufacturers have generally not published.
Comparison: Stability Claims by Format
| Format | Label Claims Examined | Public Point-of-Sale Viability Data | Editorial Assessment |
|---|---|---|---|
| Soft Chew (multiple brands) | 25-50 billion CFU | Not published | Format-inherent stability risk; viability claims difficult to verify |
| Capsule (powder) | 10-50 billion CFU | Rarely published; some refrigerated formats show better data | Lower moisture exposure improves stability profile |
| Sachet (single-serve powder) | 5-20 billion CFU | Occasionally published by manufacturer | Sealed single-serve barrier protects against repeated exposure |
| Postbiotic/Prebiotic (no live organisms) | N/A | N/A | Stability question does not apply; mechanism differs |
The table above represents editorial assessment based on publicly available information at the time of writing. It is not a laboratory analysis.
Frequently Asked Questions
Does a 30 billion CFU label guarantee 30 billion live organisms in every chew?
No. The label figure represents CFU at manufacture. Stability across the product’s shelf life depends on formulation, packaging, storage conditions, and handling. No major soft chew brand currently publishes third-party verified CFU data measured at retail purchase date across the full shelf life.
Why don’t soft chew manufacturers publish point-of-sale stability data?
Manufacturers cite proprietary formulation considerations and the cost of stability studies. The four companies that responded to our inquiries did not point to published data demonstrating viability at the end of shelf life in soft chew format.
Is the NASC seal a guarantee of CFU accuracy?
No. The NASC Quality Seal certifies adherence to GMP manufacturing protocols and successful independent audits. It does not certify the accuracy of CFU counts on individual product labels at any specific time point.
Are non-live probiotic alternatives more effective?
They are different, not necessarily more effective. Postbiotics and prebiotics work through mechanisms distinct from live probiotics. Published canine clinical evidence for some non-live formulations exists (see References), while equivalent product-specific canine evidence for many live soft chew probiotics does not.
References
- PMID: 40509062 — Canine clinical trial examining postbiotic and prebiotic oral health formulation effects on plaque and gingival indices.
- PMID: 40723482 — Canine clinical trial examining gut-skin axis outcomes with a multi-system postbiotic and prebiotic approach.
- FDA. Dietary Supplement Labeling Guide. Current guidance on CFU disclosure requirements.
- National Animal Supplement Council (NASC). Quality Seal program documentation and scope.
- Journal of Functional Foods. Review literature on probiotic viability across delivery matrices.
This content is for informational purposes only and is not a substitute for professional veterinary advice. Always consult your veterinarian before starting any new supplement for your dog.
